Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function

J P Cogswell1, C E Brown, J E Bisi

  • 1Department of Functional Genetics, Glaxo Wellcome Inc., Research Triangle Park, North Carolina 27709, USA. jpc30240@glaxowellcome.com

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|January 10, 2001
PubMed

Insights

Polo-like kinase 1 (PLK1) inhibition causes tumor cell death, not normal cells. This selective cancer cell apoptosis is not due to tumor cells being more dependent on PLK1 for mitotic progression.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Therapeutics

Background:

  • Polo-like kinase 1 (PLK1) is crucial for mitosis and a potential cancer therapeutic target.
  • PLK1 initiates the mitotic cascade by activating cdc25C phosphatase.
  • Loss of PLK1 function induces mitotic catastrophe selectively in cancer cells (HeLa) but not normal cells (Hs68).

Purpose of the Study:

  • To investigate if selective mitotic catastrophe induced by PLK1 inhibition extends to other tumor types.
  • To determine if this selectivity is due to tumor-specific dependence on PLK1 for cdc25C activation.

Main Methods:

  • Adenovirus-mediated delivery of a dominant-negative PLK1 gene to block PLK1 function.
  • Comparison of cellular responses (apoptosis, mitotic catastrophe) in various tumor cell lines and normal human mammary epithelial cells.
  • Assessment of cdc25C phosphorylation and cdk1 activation.

Main Results:

  • Dominant-negative PLK1 induced tumor-selective apoptosis in most tested tumor cell lines.
  • Mitotic catastrophe, similar to HeLa cells, occurred in some tumor lines but not in normal human mammary epithelial cells.
  • Normal cells arrested in mitosis but escaped catastrophic events like centrosome maturation loss.
  • PLK1 inhibition blocked cdc25C phosphorylation and cdk1 activation in both tumor and normal cells.

Conclusions:

  • The observed tumor-selective mitotic catastrophe is not caused by a lack of tumor cell dependence on PLK1 for cdc25C activation.
  • PLK1 inhibition represents a promising strategy for selective cancer therapy, inducing apoptosis in tumor cells while sparing normal cells.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...